Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Foramen Ovale, Patent | 12 | 2021 | 223 | 4.180 |
Why?
|
Stroke | 31 | 2023 | 9963 | 1.940 |
Why?
|
Thrombophilia | 3 | 2021 | 305 | 1.280 |
Why?
|
Subarachnoid Hemorrhage | 7 | 2021 | 1016 | 1.120 |
Why?
|
Embolism, Paradoxical | 3 | 2021 | 58 | 0.980 |
Why?
|
Gelsolin | 2 | 2014 | 190 | 0.830 |
Why?
|
Proteomics | 7 | 2017 | 3618 | 0.810 |
Why?
|
Ischemic Attack, Transient | 7 | 2021 | 934 | 0.760 |
Why?
|
Hemorrhagic Disorders | 2 | 2012 | 36 | 0.710 |
Why?
|
Atrial Appendage | 1 | 2023 | 282 | 0.690 |
Why?
|
Heart Arrest | 3 | 2023 | 1469 | 0.630 |
Why?
|
Embolism | 1 | 2020 | 409 | 0.600 |
Why?
|
Glycoproteins | 2 | 2017 | 2260 | 0.590 |
Why?
|
Hypothermia, Induced | 2 | 2017 | 747 | 0.500 |
Why?
|
Tissue Plasminogen Activator | 8 | 2022 | 1262 | 0.480 |
Why?
|
Vertebral Artery Dissection | 1 | 2013 | 48 | 0.460 |
Why?
|
Mass Spectrometry | 4 | 2021 | 2203 | 0.440 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.420 |
Why?
|
Molecular Probe Techniques | 1 | 2013 | 119 | 0.420 |
Why?
|
Matrix Metalloproteinase 9 | 5 | 2011 | 638 | 0.390 |
Why?
|
Brain Ischemia | 8 | 2020 | 3258 | 0.380 |
Why?
|
Migraine Disorders | 5 | 2020 | 1620 | 0.370 |
Why?
|
Lectins | 1 | 2013 | 514 | 0.370 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1617 | 0.360 |
Why?
|
Apolipoproteins | 1 | 2012 | 315 | 0.350 |
Why?
|
Cerebral Infarction | 2 | 2013 | 1007 | 0.340 |
Why?
|
ROC Curve | 2 | 2017 | 3528 | 0.330 |
Why?
|
Blood Proteins | 3 | 2012 | 1122 | 0.320 |
Why?
|
Endothelial Cells | 5 | 2022 | 3455 | 0.320 |
Why?
|
Brain | 15 | 2022 | 26343 | 0.320 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1438 | 0.320 |
Why?
|
Microglia | 4 | 2020 | 1261 | 0.310 |
Why?
|
Blood-Brain Barrier | 2 | 2017 | 1015 | 0.310 |
Why?
|
Recurrence | 6 | 2021 | 8333 | 0.300 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 457 | 0.290 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4414 | 0.290 |
Why?
|
Brain Edema | 1 | 2011 | 617 | 0.290 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1157 | 0.280 |
Why?
|
Fibrinolytic Agents | 6 | 2022 | 2156 | 0.270 |
Why?
|
Thrombolytic Therapy | 7 | 2022 | 2161 | 0.270 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2006 | 149 | 0.270 |
Why?
|
Peptide Hydrolases | 1 | 2009 | 627 | 0.270 |
Why?
|
Cerebrovascular Disorders | 1 | 2012 | 1499 | 0.270 |
Why?
|
Endothelium, Vascular | 3 | 2018 | 4455 | 0.260 |
Why?
|
Treatment Outcome | 15 | 2023 | 62966 | 0.260 |
Why?
|
Proteome | 3 | 2012 | 1790 | 0.260 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1060 | 0.250 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2005 | 65 | 0.250 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5019 | 0.250 |
Why?
|
Oxidative Stress | 3 | 2010 | 3081 | 0.250 |
Why?
|
Septal Occluder Device | 3 | 2020 | 129 | 0.240 |
Why?
|
Intracranial Aneurysm | 1 | 2014 | 1197 | 0.240 |
Why?
|
Blood Vessels | 1 | 2009 | 1124 | 0.220 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1025 | 0.210 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2861 | 0.200 |
Why?
|
Humans | 60 | 2023 | 742088 | 0.200 |
Why?
|
Sinus Thrombosis, Intracranial | 2 | 2013 | 103 | 0.200 |
Why?
|
Streptococcal Infections | 1 | 2005 | 637 | 0.190 |
Why?
|
Influenza, Human | 1 | 2011 | 1472 | 0.180 |
Why?
|
Signal Transduction | 3 | 2013 | 23387 | 0.180 |
Why?
|
Coma | 1 | 2023 | 475 | 0.180 |
Why?
|
Male | 39 | 2021 | 349538 | 0.170 |
Why?
|
Alzheimer Disease | 2 | 2022 | 7988 | 0.160 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2022 | 855 | 0.160 |
Why?
|
Brain Death | 1 | 2001 | 347 | 0.160 |
Why?
|
Spinal Injuries | 1 | 2001 | 301 | 0.160 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1889 | 0.150 |
Why?
|
Homocysteine | 1 | 2021 | 647 | 0.150 |
Why?
|
Ceruloplasmin | 1 | 2017 | 56 | 0.150 |
Why?
|
Annexin A2 | 1 | 2017 | 44 | 0.150 |
Why?
|
Anticoagulants | 2 | 2023 | 4595 | 0.140 |
Why?
|
Echocardiography | 2 | 2020 | 5097 | 0.140 |
Why?
|
Algorithms | 2 | 2019 | 13853 | 0.140 |
Why?
|
Haptoglobins | 1 | 2017 | 165 | 0.140 |
Why?
|
Secondary Prevention | 2 | 2020 | 1520 | 0.140 |
Why?
|
Female | 29 | 2021 | 379592 | 0.140 |
Why?
|
Extracellular Fluid | 1 | 2017 | 166 | 0.140 |
Why?
|
Middle Aged | 22 | 2021 | 213127 | 0.140 |
Why?
|
Extracellular Space | 1 | 2018 | 594 | 0.130 |
Why?
|
Central Nervous System Diseases | 2 | 2018 | 518 | 0.130 |
Why?
|
Intracranial Embolism | 2 | 2017 | 202 | 0.130 |
Why?
|
Oxygen | 2 | 2018 | 4169 | 0.130 |
Why?
|
Cadherins | 1 | 2020 | 906 | 0.130 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 12071 | 0.130 |
Why?
|
Cervical Vertebrae | 1 | 2001 | 973 | 0.130 |
Why?
|
Endocarditis | 1 | 2019 | 348 | 0.130 |
Why?
|
Glucose | 2 | 2018 | 4391 | 0.130 |
Why?
|
Mitochondria | 2 | 2018 | 3520 | 0.120 |
Why?
|
Prospective Studies | 7 | 2021 | 53187 | 0.120 |
Why?
|
Magnetic Resonance Angiography | 3 | 2013 | 1440 | 0.120 |
Why?
|
Diagnostic Errors | 1 | 2001 | 1255 | 0.120 |
Why?
|
Neurologic Examination | 1 | 2017 | 931 | 0.120 |
Why?
|
Coronary Circulation | 1 | 2020 | 1572 | 0.120 |
Why?
|
Adult | 18 | 2021 | 213712 | 0.120 |
Why?
|
Spinal Cord Injuries | 1 | 2001 | 930 | 0.110 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 854 | 0.110 |
Why?
|
Astrocytes | 2 | 2018 | 1266 | 0.110 |
Why?
|
Recovery of Function | 3 | 2020 | 2924 | 0.100 |
Why?
|
Polyvinyls | 1 | 2013 | 157 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1368 | 0.100 |
Why?
|
Endothelin-1 | 1 | 2013 | 313 | 0.100 |
Why?
|
Animals | 22 | 2022 | 168561 | 0.100 |
Why?
|
Metalloendopeptidases | 1 | 2013 | 396 | 0.100 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2013 | 311 | 0.100 |
Why?
|
Chemokines | 1 | 2016 | 954 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1067 | 0.100 |
Why?
|
Limit of Detection | 1 | 2012 | 264 | 0.100 |
Why?
|
Membranes, Artificial | 1 | 2013 | 378 | 0.100 |
Why?
|
Interleukins | 1 | 2016 | 791 | 0.100 |
Why?
|
Dizziness | 1 | 2013 | 250 | 0.100 |
Why?
|
Prognosis | 8 | 2023 | 29010 | 0.100 |
Why?
|
Papilledema | 1 | 2012 | 118 | 0.100 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2013 | 425 | 0.100 |
Why?
|
Cell Communication | 1 | 2018 | 1619 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2024 | 0.090 |
Why?
|
Vomiting | 1 | 2013 | 632 | 0.090 |
Why?
|
Dipyridamole | 1 | 2010 | 145 | 0.090 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 1801 | 0.090 |
Why?
|
Inflammation | 4 | 2022 | 10578 | 0.090 |
Why?
|
Nerve Regeneration | 1 | 2016 | 791 | 0.090 |
Why?
|
Rats, Wistar | 3 | 2022 | 1902 | 0.090 |
Why?
|
Free Radical Scavengers | 1 | 2010 | 217 | 0.090 |
Why?
|
Cytotoxins | 1 | 2010 | 153 | 0.090 |
Why?
|
Aged | 14 | 2021 | 162944 | 0.090 |
Why?
|
Glycosylation | 1 | 2013 | 1123 | 0.090 |
Why?
|
Fibrinogen | 1 | 2013 | 894 | 0.090 |
Why?
|
Biomedical Technology | 1 | 2012 | 221 | 0.090 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2623 | 0.090 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2010 | 215 | 0.090 |
Why?
|
Antigens, CD | 1 | 2020 | 4024 | 0.090 |
Why?
|
Protein Isoforms | 1 | 2014 | 1727 | 0.080 |
Why?
|
Chromatography, Liquid | 1 | 2012 | 977 | 0.080 |
Why?
|
Hydrocephalus | 2 | 2013 | 746 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3278 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15108 | 0.080 |
Why?
|
F2-Isoprostanes | 1 | 2007 | 35 | 0.080 |
Why?
|
Thrombospondin 1 | 1 | 2009 | 250 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3067 | 0.080 |
Why?
|
Rats | 6 | 2022 | 24265 | 0.080 |
Why?
|
Time Factors | 7 | 2020 | 40054 | 0.070 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2008 | 145 | 0.070 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2006 | 80 | 0.070 |
Why?
|
Pneumocephalus | 1 | 2006 | 46 | 0.070 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2012 | 1121 | 0.070 |
Why?
|
Convalescence | 1 | 2006 | 105 | 0.070 |
Why?
|
Enzyme Induction | 1 | 2006 | 475 | 0.070 |
Why?
|
Spinal Cord Diseases | 1 | 2008 | 299 | 0.070 |
Why?
|
Heart Diseases | 1 | 2018 | 2789 | 0.070 |
Why?
|
Brain Damage, Chronic | 1 | 2006 | 265 | 0.070 |
Why?
|
Cerebral Hemorrhage | 3 | 2009 | 2643 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2013 | 21719 | 0.060 |
Why?
|
Iatrogenic Disease | 1 | 2008 | 545 | 0.060 |
Why?
|
Cerebral Arteries | 1 | 2007 | 492 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1989 | 0.060 |
Why?
|
Prostatic Hyperplasia | 1 | 2008 | 522 | 0.060 |
Why?
|
Plasminogen Activators | 1 | 2004 | 209 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16331 | 0.060 |
Why?
|
Age Factors | 2 | 2016 | 18355 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1213 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3239 | 0.060 |
Why?
|
Deoxyribonucleases | 1 | 2005 | 214 | 0.060 |
Why?
|
Leukocytosis | 1 | 2005 | 247 | 0.060 |
Why?
|
Retinal Diseases | 2 | 2000 | 683 | 0.060 |
Why?
|
Methylprednisolone | 1 | 2005 | 388 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57683 | 0.060 |
Why?
|
Pharyngitis | 1 | 2005 | 215 | 0.060 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18006 | 0.060 |
Why?
|
Ischemia | 1 | 2012 | 1911 | 0.060 |
Why?
|
Epilepsy | 1 | 2018 | 3301 | 0.050 |
Why?
|
China | 2 | 2019 | 2246 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6483 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2012 | 3199 | 0.050 |
Why?
|
Eye Diseases | 1 | 2008 | 670 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2006 | 1583 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 56350 | 0.050 |
Why?
|
Cell Hypoxia | 2 | 2018 | 675 | 0.050 |
Why?
|
Basal Ganglia | 1 | 2005 | 545 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2004 | 17400 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5724 | 0.050 |
Why?
|
Cohort Studies | 3 | 2018 | 40450 | 0.050 |
Why?
|
Echo-Planar Imaging | 1 | 2006 | 659 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2010 | 2128 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 3 | 2018 | 8300 | 0.050 |
Why?
|
Neurons | 2 | 2018 | 9325 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2022 | 281 | 0.050 |
Why?
|
Nasal Polyps | 1 | 2006 | 360 | 0.050 |
Why?
|
Neostigmine | 1 | 2021 | 69 | 0.050 |
Why?
|
Contraceptives, Oral | 1 | 2004 | 563 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 12958 | 0.050 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2005 | 657 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2009 | 1155 | 0.050 |
Why?
|
Sulfur Hexafluoride | 1 | 2000 | 25 | 0.050 |
Why?
|
Silicone Oils | 1 | 2000 | 22 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 18112 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 21821 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13814 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 19223 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2001 | 570 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4465 | 0.040 |
Why?
|
Air | 1 | 2000 | 181 | 0.040 |
Why?
|
Cell Line | 2 | 2010 | 15994 | 0.040 |
Why?
|
Aging | 1 | 2018 | 8626 | 0.040 |
Why?
|
Pregnancy | 2 | 2016 | 29087 | 0.040 |
Why?
|
Heart | 1 | 2012 | 4462 | 0.040 |
Why?
|
Critical Care | 1 | 2012 | 2640 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1554 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3862 | 0.040 |
Why?
|
Retina | 2 | 2000 | 2611 | 0.040 |
Why?
|
Risk Factors | 5 | 2020 | 72145 | 0.040 |
Why?
|
Aplysia | 1 | 1998 | 41 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8455 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 534 | 0.040 |
Why?
|
Insulin | 1 | 2012 | 6575 | 0.040 |
Why?
|
Reperfusion | 1 | 2018 | 284 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2010 | 707 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2022 | 1121 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 494 | 0.040 |
Why?
|
Long-Term Potentiation | 1 | 1998 | 293 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2018 | 292 | 0.030 |
Why?
|
Mice | 6 | 2022 | 81045 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 297 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2010 | 1155 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 5979 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2006 | 2002 | 0.030 |
Why?
|
Neurons, Afferent | 1 | 1998 | 508 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 1788 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 35342 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7141 | 0.030 |
Why?
|
Fluorocarbons | 1 | 2000 | 452 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2019 | 522 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 11695 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20086 | 0.030 |
Why?
|
Microvessels | 1 | 2018 | 544 | 0.030 |
Why?
|
Neovascularization, Physiologic | 2 | 2012 | 1350 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2020 | 2736 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2017 | 798 | 0.030 |
Why?
|
Serotonin | 1 | 1998 | 1024 | 0.030 |
Why?
|
Bradykinin | 1 | 2013 | 214 | 0.030 |
Why?
|
Benzofurans | 1 | 2013 | 140 | 0.030 |
Why?
|
Neuroglia | 1 | 2018 | 925 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 2723 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2018 | 1692 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2007 | 15530 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 941 | 0.030 |
Why?
|
Species Specificity | 1 | 2016 | 2479 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2019 | 15244 | 0.020 |
Why?
|
Intracranial Thrombosis | 1 | 2012 | 113 | 0.020 |
Why?
|
Databases, Protein | 1 | 2012 | 383 | 0.020 |
Why?
|
Glycemic Index | 1 | 2012 | 395 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15056 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9735 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3574 | 0.020 |
Why?
|
Patient Selection | 2 | 2013 | 4214 | 0.020 |
Why?
|
Hospitals, General | 1 | 2013 | 749 | 0.020 |
Why?
|
Iliac Vein | 1 | 2009 | 72 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2266 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 1095 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 3001 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1670 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 472 | 0.020 |
Why?
|
Vitreous Body | 2 | 2000 | 389 | 0.020 |
Why?
|
Neuroimmunomodulation | 1 | 2009 | 152 | 0.020 |
Why?
|
Phlebography | 1 | 2009 | 333 | 0.020 |
Why?
|
Posterior Cerebral Artery | 1 | 2007 | 24 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6608 | 0.020 |
Why?
|
Anterior Cerebral Artery | 1 | 2007 | 48 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2004 | 4250 | 0.020 |
Why?
|
alpha-Tocopherol | 1 | 2007 | 127 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2004 | 4566 | 0.020 |
Why?
|
Injections | 2 | 2000 | 840 | 0.020 |
Why?
|
Basilar Artery | 1 | 2007 | 200 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4211 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2007 | 264 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2020 | 77098 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2713 | 0.020 |
Why?
|
Myocardium | 1 | 2018 | 4775 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7901 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 85649 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3937 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2006 | 39004 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2001 | 8925 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 2007 | 647 | 0.020 |
Why?
|
Urinary Incontinence | 1 | 2008 | 494 | 0.020 |
Why?
|
Oligopeptides | 1 | 2009 | 1176 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1695 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2295 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13403 | 0.010 |
Why?
|
Metabolomics | 1 | 2012 | 1467 | 0.010 |
Why?
|
Rabbits | 2 | 2000 | 4886 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6534 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7790 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9941 | 0.010 |
Why?
|
Quality of Life | 1 | 2004 | 12730 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3800 | 0.010 |
Why?
|
Matrix Metalloproteinases | 1 | 2004 | 391 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3248 | 0.010 |
Why?
|
Vasoconstriction | 1 | 2004 | 596 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15194 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2007 | 1459 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9305 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9387 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5872 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2006 | 1407 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2007 | 1827 | 0.010 |
Why?
|
Antioxidants | 1 | 2007 | 1659 | 0.010 |
Why?
|
Blood Glucose | 1 | 2012 | 6249 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14720 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 24913 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5212 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2007 | 1952 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2004 | 1740 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 286 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9410 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2000 | 1799 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1998 | 489 | 0.010 |
Why?
|
Genomics | 1 | 2012 | 5692 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 491 | 0.010 |
Why?
|
Safety | 1 | 2000 | 1185 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 2049 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14554 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2000 | 1167 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1998 | 1802 | 0.010 |
Why?
|
Survivors | 1 | 2004 | 2286 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2837 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 2257 | 0.010 |
Why?
|
Blood Pressure | 1 | 2008 | 8541 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4322 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1998 | 3701 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 20928 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1998 | 2440 | 0.010 |
Why?
|
Base Sequence | 1 | 1998 | 12797 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 1998 | 5851 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 1998 | 9639 | 0.000 |
Why?
|